Literature DB >> 17907194

Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.

Esther Reefman1, Gerda Horst, Marije T Nijk, Pieter C Limburg, Cees G M Kallenberg, Marc Bijl.   

Abstract

OBJECTIVE: Decreased clearance of apoptotic cells is suggested to be a major pathogenic factor in systemic lupus erythematosus (SLE). The aim of this study was to investigate whether the binding of SLE autoantibodies to apoptotic cells influences the phagocytosis of these cells by macrophages.
METHODS: Apoptosis was induced in a human T cell line (Jurkat) and a keratinocyte cell line (HaCaT) by ultraviolet B irradiation. Binding of purified IgG from 26 SLE patients and 15 healthy controls to apoptotic cells was assessed by flow cytometry and Western blotting. Phagocytosis of IgG-opsonized apoptotic cells by monocyte-derived macrophages was assessed by light microscopy. Similar experiments were performed with a monoclonal antibody against SSA/Ro and IgG fractions from 5 patients with Sjögren's syndrome (SS) and 5 patients with rheumatoid arthritis (RA).
RESULTS: IgG fractions from all 26 SLE patients bound to late apoptotic, but not early apoptotic, cells. IgG fractions isolated from SLE patients with different autoantibody profiles showed comparable levels of binding. IgG fractions from healthy controls did not bind. Opsonization of apoptotic cells with IgG fractions from SLE patients resulted in a significant inhibition of phagocytosis as compared with healthy control IgG fractions. A monoclonal antibody directed against SSA/Ro and IgG isolated from 5 antinuclear antibody (ANA)-positive patients with SS were also able to elicit these effects, whereas IgG from 5 ANA-negative patients with RA did not. The inhibitory effect of patient IgG was abolished by blocking either the Fcgamma receptors (FcgammaR) or the constant region of IgG, using a specific Fc-blocking peptide.
CONCLUSION: Autoantibodies from SLE patients are able to opsonize apoptotic cells and inhibit their uptake by macrophages via an FcgammaR-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907194     DOI: 10.1002/art.22947

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

Review 1.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

Review 2.  The role of defective clearance of apoptotic cells in systemic autoimmunity.

Authors:  Luis E Muñoz; Kirsten Lauber; Martin Schiller; Angelo A Manfredi; Martin Herrmann
Journal:  Nat Rev Rheumatol       Date:  2010-05       Impact factor: 20.543

3.  Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.

Authors:  K A Young; D R Terrell; J M Guthridge; D L Kamen; G S Gilkeson; D R Karp; M L Ishimori; M H Weisman; V M Holers; J B Harley; J M Norris; J A James
Journal:  Lupus       Date:  2014-01-21       Impact factor: 2.911

4.  SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus.

Authors:  April M Jorge; Taotao Lao; Rachel Kim; Samantha Licciardi; Joseph El Khoury; Andrew D Luster; Terry K Means; Zaida G Ramirez-Ortiz
Journal:  J Immunol       Date:  2022-01-26       Impact factor: 5.422

Review 5.  Extracellular DNA and autoimmune diseases.

Authors:  Hantao Lou; Matthew C Pickering
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

6.  Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages.

Authors:  R Subramaniam; S Mukherjee; H Chen; S Keshava; P Neuenschwander; H Shams
Journal:  Mucosal Immunol       Date:  2015-11-18       Impact factor: 7.313

7.  Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.

Authors:  Christopher Richardson; Asiya Seema Chida; Diana Adlowitz; Lin Silver; Erin Fox; Scott A Jenks; Elise Palmer; Youliang Wang; Jamie Heimburg-Molinaro; Quan-Zhen Li; Chandra Mohan; Richard Cummings; Christopher Tipton; Ignacio Sanz
Journal:  J Immunol       Date:  2013-10-09       Impact factor: 5.422

8.  9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.

Authors:  Scott A Jenks; Elise M Palmer; Elides Y Marin; Louise Hartson; Asiya Seema Chida; Christopher Richardson; Ignacio Sanz
Journal:  Arthritis Rheum       Date:  2013-12

9.  Smoking associates with distinct clinical phenotypes in patients with systemic lupus erythematosus: a nationwide Danish cross-sectional study.

Authors:  Henrik Christian Bidstrup Leffers; Anne Troldborg; Anne Voss; Salome Kristensen; Jesper Lindhardsen; Prabhat Kumar; Asta Linauskas; Lars Juul; Niels Steen Krogh; Bent Deleuran; Lene Dreyer; Søren Jacobsen
Journal:  Lupus Sci Med       Date:  2021-04

10.  Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus.

Authors:  Andrew J Monteith; SunAh Kang; Eric Scott; Kai Hillman; Zenon Rajfur; Ken Jacobson; M Joseph Costello; Barbara J Vilen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.